ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 14.4% on Monday . The stock traded as high as GBX 3.90 ($0.05) and last traded at GBX 3.59 ($0.05). Approximately 3,398,434 shares changed hands during trading, a decline of 75% from the average daily volume of 13,390,035 shares. The stock had previously closed at GBX 3.14 ($0.04).
ImmuPharma Stock Up 13.5 %
The firm has a fifty day moving average price of GBX 3.80 and a two-hundred day moving average price of GBX 2.34. The stock has a market capitalization of £15.13 million, a P/E ratio of -6.16 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
See Also
- Five stocks we like better than ImmuPharma
- Financial Services Stocks Investing
- How to Build the Ultimate Everything ETF Portfolio
- Conference Calls and Individual Investors
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
